Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Recruiting

• Conditions: Melanoma

• Registration Number: NCT01205815
• Lead Sponsor: Vanderbilt-Ingram Cancer Center

Brief Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06-03
• Study First Submitted: 2010-09-17
• Study First Submitted QC: 2010-09-17
• Study First Posted: 2010-09-21
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-05
• Last Update Posted: 2024-02-07
• Primary Completion: 2025-01
• Study Completion: 2025-08

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Molecular changes in patients' melanoma tissue	at 120 months	Tissue is collected upon consent or upon receipt of parafin block, primary aim will be met when all tissues are collected and analyzed at conclusion of study. Intent is to aid patients and their treating physician when making treatment decisions.

Secondary Outcome Measures

Name	Time	Method
Improve the time between ordering the test and results entry into medical records	120 months	To enhance the speed and detail of molecular mutation profiling of melanoma

Trial Locations

Locations (1)

Vanderbitl-Ingram Cancer Center; 🇺🇸 Nashville, Tennessee, United States